Speciality Medi.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0R0M01014
  • NSEID:
  • BSEID: 544738
INR
200.10
-8.8 (-4.21%)
BSENSE

Jun 18

BSE+NSE Vol: 2000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is 76.57% vs -21.43% in Mar 2024

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2025 is 100.00% vs 200.00% in Mar 2024

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is 34.01% vs -13.02% in Mar 2024

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 73.93% vs 84.66% in Mar 2024

Compare Balance Sheet Results of Speciality Medi.
Markets Mojo
Figures in Cr
Standalone - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
6.44
11.88
-5.44
-45.79%
Share Warrants & Outstandings
Total Reserve
23.98
24.76
-0.78
-3.15%
Shareholder's Funds
30.42
38.00
-7.58
-19.95%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
3.85
5.29
-1.44
-27.22%
Secured Loans
0.72
5.23
-4.51
-86.23%
Unsecured Loans
3.13
0.06
3.07
5,116.67%
Deferred Tax Assets / Liabilities
0.03
0.77
-0.74
-96.10%
Other Long Term Liabilities
0.12
0.00
0.12
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.48
-0.48
-100.00%
Total Non-Current Liabilities
2.77
6.53
-3.76
-57.58%
Current Liabilities
Trade Payables
0.97
15.25
-14.28
-93.64%
Other Current Liabilities
3.39
3.33
0.06
1.80%
Short Term Borrowings
2.44
0.34
2.10
617.65%
Short Term Provisions
0.00
1.54
-1.54
-100.00%
Total Current Liabilities
6.80
20.46
-13.66
-66.76%
Total Liabilities
39.98
65.00
-25.02
-38.49%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
2.80
28.26
-25.46
-90.09%
Less: Accumulated Depreciation
0.84
7.70
-6.86
-89.09%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
1.97
20.56
-18.59
-90.42%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.10
3.00
-2.90
-96.67%
Long Term Loans & Advances
0.03
2.05
-2.02
-98.54%
Other Non Current Assets
1.46
1.28
0.18
14.06%
Total Non-Current Assets
3.56
26.89
-23.33
-86.76%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
17.38
10.42
6.96
66.79%
Sundry Debtors
9.58
16.68
-7.10
-42.57%
Cash and Bank
0.85
1.56
-0.71
-45.51%
Other Current Assets
0.88
0.09
0.79
877.78%
Short Term Loans and Advances
7.73
9.36
-1.63
-17.41%
Total Current Assets
36.42
38.10
-1.68
-4.41%
Net Current Assets (Including Current Investments)
29.62
17.64
11.98
67.91%
Total Current Assets Excluding Current Investments
36.42
38.10
-1.68
-4.41%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
39.98
65.00
-25.02
-38.49%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
3.80
5.62
-1.82
-32.38%
Book Value per share (adjusted)
47.26
30.84
16.42
53.24%
Annual - Borrowings
Borrowings 5.05 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 76.57% vs -21.43% in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.12 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 100.00% vs 200.00% in Mar 2024

Annual - Fixed Assets
Fixed Assets 1.97 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 34.01% vs -13.02% in Mar 2024

Annual - Investments
Investments 0.10 Cr
in Mar 2025

Figures in Cr
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 36.42 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 73.93% vs 84.66% in Mar 2024